National Health Determination under paragraph 98C(1)(b) Amendment 2015 (No. 4) (PB 41 of 2015)

Link to law: https://www.comlaw.gov.au/Details/F2015L00589

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now
PB 41 of 2015
 
National Health Determination under paragraph 98C(1)(b) Amendment 2015
(No. 4)
_____________________________________________________________________
 
 
I, FELICITY McNEILL, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Instrument under paragraph 98C(1)(b) of the National Health Act 1953.
 
Dated 22 April 2015
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FELICITY McNEILL
First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health
 
 
 
1              Name of Instrument
(1)                This Instrument is the National Health Determination under paragraph 98C(1)(b) Amendment 2015 (No. 4).
(2)                This Instrument may also be cited as PB 41 of 2015.
2              Commencement                                                        
                This instrument commences on 1 May 2015.
3              Amendments to Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008)
                Schedule 1 amends the Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008).
Schedule 1            Amendments
 
[1]           Schedule 4, after entry for Latanoprost with Timolol
insert:
Leuprorelin
I.M. injection (3 month modified release), powder for injection containing leuprorelin acetate 30 mg with diluent in pre-filled dual-chamber syringe
[2]           Schedule 4, entry for Oestradiol
omit:
 
Vaginal tablets 25 micrograms, 15